Fiasco in Phase III: Roche’s conditionally approved PD-L1 checkpoint inhibitor did not meet the endpoint of...
Up To Date
Latest News
Mucosal inflammation specialist Dermtreat ApS (Copenhagen) has secured a Series A financing worth €16.2m...
GMO world market adoption is further growing. GMO cultivation area in 2016 increased to 185.1 million hectares...
With an impressive 11.7% growth in sales compared with 2015, the Swiss biotech sector has grown more strongly...
The Biotechnology in Germany is a growth engine. According to a new report, all key figures such as employees,...
The french biotechnology company Vivet Therapeutics has raised €37.5 million in a Series A financing round....
Share
